ERS International Congress 2022: highlights from the Sleep Disordered Breathing Assembly.

During the European Respiratory Society (ERS) International Congress 2022 in Barcelona, Spain, the latest research and clinical topics in respiratory medicine were presented. The sleep medicine-focused presentations and symposia provided novel insights into the pathophysiology of sleep disordered breathing, its diagnostics, and new trends in translational research and clinical applications. The presented research trends focused mainly on the assessment of sleep disordered breathing-related intermittent hypoxia, inflammation and sleep fragmentation, and their implications, especially cardiovascular. The most promising methods for assessing these aspects encompass genomics, proteomics and cluster analysis. The currently available options include positive airway pressure and a combination of it and pharmacological agents ( e.g. sulthiame). This article summarises the most relevant studies and topics on these subjects presented at the ERS International Congress 2022. Each section has been written by Early Career Members of the ERS Assembly 4.
Competing Interests: Conflict of interest: M. Bradicich declares support from the European Respiratory Society for acting as faculty at the society's 2022 International Congress; and an unpaid role as Early Career Member Representative for European Respiratory Society Assembly 4 (Sleep Disordered Breathing). W. Randerath declares payment or honoraria from Heinen & Löwenstein, Resmed, Jazz Pharmaceuticals, Inspire, Philips Respironics, Bioprojet and Westfalen Medical; support for attending meetings and/or travel from Heinen & Löwenstein, Jazz Pharmaceuticals, Philips Respironics and Bioprojet; and participation on a data safety monitoring or advisory board from Bioprojet, Jazz Pharmaceuticals, Philips Respironics and Procter & Gamble, all in the 36 months prior to manuscript submission; as well as an unpaid role as head of European Respiratory Society Assembly 4 (Sleep Disordered Breathing). He is an associate editor of this journal. All other authors declare no competing interests.
(Copyright ©The authors 2023.)